Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 13;25(1):211.
doi: 10.1186/s12879-025-10606-1.

Metabolomics assays applied to schistosomiasis studies: a scoping review

Affiliations

Metabolomics assays applied to schistosomiasis studies: a scoping review

Milena Lima Rodrigues et al. BMC Infect Dis. .

Abstract

Background: Metabolomics is an analytical approach utilized to explore the metabolic profiles of biological systems. This process typically involves the application of techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). In the case of schistosomiasis, metabolomics has been employed to identify potential diagnostic biomarkers, examine the host's metabolic response, and explore more effective therapeutic strategies. The objective of this scoping review is to assess the scope and characteristics of metabolomic research on schistosomiasis conducted over the past decade.

Methods: To identify relevant original publications, a systematic search was conducted in the PubMed and Web of Science databases using the following search terms: ("Metabolomics" OR "Metabolomic" OR "Metabonomics" OR "Metabonomic") AND ("Schistosomiasis" OR "Schistosoma"). These terms were applied to the titles and abstracts of the publications, with a focus on the period from January 2014 to December 2024.

Results: The initial search yielded 48 articles. However, after a thorough evaluation of the abstracts, 14 articles were selected based on the established inclusion criteria. The selection process is visually depicted in the PRISMA flowchart. The majority of the studies included in this review were conducted in China (7 articles) and Brazil (3 articles). Approximately two-thirds of the studies utilized animal models, with serum serving as biofluid in 66% of the studies. The findings of this scoping review suggest that chromatographic techniques coupled with mass spectrometry are predominantly used in metabolomic research on schistosomiasis, accounting for 75% of the studies. The identified metabolites are associated with metabolic pathways related to glycolysis, the TCA cycle, and amino acid metabolism, as well as demonstrating alterations resulting from intestinal dysbiosis observed during the infection. As exemplified by succinate and citrate, which are present in the alterations of energy pathways in Schistosoma mansoni and Schistosoma japonicum species. The serum levels of these metabolites are modified, reflecting the host's metabolic and immunological responses induced by the infections.

Conclusions: These studies successfully elucidated the metabolic pathways and key metabolites involved in schistosomiasis. The findings are significant for the future identification of diagnostic biomarkers and the development of novel antiparasitic agents targeting Schistosoma species.

Clinical trial: Not Applicable.

Keywords: Biomarkers; Diagnostic technique; Metabonomics; Schistosomiasis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not Applicable. Consent for publication: All authors authorize the publication of this manuscript. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
The PRISMA diagram for the scoping review, using the terms (“Metabolomics OR Metabolomic OR Metabonomics OR Metabonomic”) AND (“Schistosomiasis OR Schistosoma”), published between Jan/2014 and Dec/2024
Fig. 2
Fig. 2
Relation of altered metabolites in serum or urine of humans and rats induced by S japonicum and S mansoni observed in 10 published articles

References

    1. Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature. 2008;455(7216):1054–6. - PubMed
    1. Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016;15(7):473–84. - PubMed
    1. Xie G, Wang L, Chen T, Zhou K, Zhang Z, Li J, et al. A metabolite array technology for Precision Medicine. Anal Chem. 2021;93(14):5709–17. - PubMed
    1. Wishart DS, Cheng LL, Copié V, Edison AS, Eghbalnia HR, Hoch JC, et al. NMR and Metabolomics—A Roadmap for the future. Metabolites. 2022;12(8):678. - PMC - PubMed
    1. Oliveira MF, de Albuquerque Neto MC, Leite TS, Alves PAA, Lima SVC, Silva RO. Performance evaluate of different chemometrics formalisms used for prostate cancer diagnosis by NMR-based metabolomics. Metabolomics. 2023;20(1):8. - PubMed

Publication types

LinkOut - more resources